Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...

The Roivant company is dedicated to developing and commercializing innovative therapeutics in immune-dermatology.

Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Organon (OGN – Research Report), retaining the price target of ...

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis ...

Organon is paying $175 million upfront to buy Roivant's dermatology unit Dermavant and its topical psoriasis therapy Vtama, ...

Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European ...

Purohit’s optimistic outlook is influenced by the recent acquisition of Dermavant by Organon, a move that underscores the value and commercial potential of branded topical dermatology treatments. The ...

NICE has recommended Vanflyta (quizartinib) for routine NHS commissioning as an induction, consolidation, and maintenance ...

GC Therapeutics claims it can create off-the-shelf therapies from induced pluripotent stem cells much faster than with current methods by using a simpler process.

ANN ARBOR, Michigan — As vice president, Kamala Harris has been part of an administration that’s poured more than $50 billion into Rust Belt industry and infrastructure. As the Democrats ...

EY Pune employee's death: Shobha Karandlaje was responding to Rajeev Chandrasekhar's post who called the woman's death very sad and “disturbing at many levels”.

Australia's unemployment rate remained at 4.2 per cent in August, as employment grew by 47,500 people.